New Market Gives More Providers Opportunity to Participate in Value-Based Care Programs
TAMPA, Fla., May 28, 2024 /PRNewswire/ -- Collaborative Health Systems (CHS), a management services organization for providers and wholly owned subsidiary of Centene Corporation (NYSE: CNC), recently announced expansion into a new market, offering providers in Virginia an opportunity to join Chesapeake Independent Physician Association (CIPA) to drive greater collaboration around value-based care.
CIPA, managed by Collaborative Health Systems and operating in Maryland since 2018, includes more than 150 provider groups and two Medicare Shared Savings Programs (MSSP), Medicare Advantage (MA) plans, and several commercial health plan programs. The IPA also offers participating practices the benefits derived from belonging to a larger group, including improved Medicare Fee-For-Service rates, value-based programs offered by health plans and financial incentives.
"This is an exciting step in our business initiatives and growth efforts to align with providers who are focused on succeeding in value-based care," said Anthony Valdés, president of Collaborative Health Systems. "We look forward to welcoming new providers into our network."
Practices that participate in CIPA have a trusted partner that can offer tools and resources to coordinate care, engage with patients and provide administrative support. Other participation benefits include working alongside healthcare providers who have a vested interest in value-based care, reducing practice costs, improving operational efficiency, increasing practice revenue and achieving greater patient health outcomes.
For more information about Chesapeake Independent Physician Association, click here.
About Collaborative Health Systems (CHS)
Collaborative Health Systems (CHS) is a management services organization that partners with independent primary care physicians as they move to value-based models. Its core belief is that primary care physicians are in the best position to influence the quality and cost of healthcare. CHS provides comprehensive support for its physician partners by providing management services, risk contracting and population health capabilities, including actionable data and other tools, to deliver care coordination and closure of gaps in care. CHS provides additional services to secure and deliver favorable value-based contracts with commercial and other health plans. CHS currently manages four REACH ACOs, six MSSP ACOs, three Independent Physician Associations and a Care Transformation Organization. CHS additionally contracts with private payers to help its providers expand their participation in value-based care across lines of business such as Medicare Advantage. CHS is a wholly owned subsidiary of Centene Corporation, a leading healthcare enterprise committed to helping people live healthier lives. For more information, visit www.CollaborativeHealthSystems.com.
Last Trade: | US$70.83 |
Daily Change: | -1.83 -2.52 |
Daily Volume: | 4,604,229 |
Market Cap: | US$37.260B |
August 29, 2024 July 26, 2024 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB